Medical Weight Loss for Holyoke, Massachusetts Residents

Holyoke, Massachusetts residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Holyoke through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Start this week from Holyoke: book a video visit, complete your intake, and if you are a fit, your compounded medication ships to your Massachusetts door. No travel to California required. Doctor review just $119 (medication separate).

Why Holyoke Residents Choose New Hope Weight Loss

If past attempts left you frustrated, Holyoke, the difference here is structure and honesty. There is a real physician, Dr. Anjmun Sharma, behind your plan, a transparent price you can see up front, and a program that meets you by telehealth instead of dragging you across Massachusetts for every visit. Compounded semaglutide and tirzepatide are not magic and they are not FDA-approved, but paired with steady medical guidance they give a lot of people a genuine path forward.

If you are searching for medical weight loss in Holyoke, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

New Hope Weight Loss is based in Costa Mesa, yet a patient in Holyoke sees the same doctor, takes the same approach, and pays the same prices, all through telehealth across Massachusetts. We care for patients throughout downtown Holyoke and the greater Pioneer Valley of Hampden County. You can have your first video visit from your kitchen in Holyoke and have your treatment plan in motion the same week.

Distance simply stops mattering here, since every appointment for Holyoke residents takes place over secure video rather than in a waiting room. Compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and for Holyoke patients it starts at $166 per month, billed separately. Across the densely populated communities of Massachusetts, New Hope Weight Loss cares for patients by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

The 90-Day Metabolic Reset (Semaglutide)

Think of this as a focused three-month plan. Semaglutide carries the same active ingredient as Wegovy and Ozempic, and the branded versions averaged about 15 to 17 percent body-weight loss in trials. Pricing is from $166/mo, with the full 90 days at $499, and Dr. Sharma adjusts your dose along the way. Compounded semaglutide is not FDA-approved, not brand-identical, and individual results vary.

Advanced Program (Tirzepatide)

From $233/mo, tirzepatide engages two metabolic pathways, GLP-1 and GIP. Trials of the branded drug reached up to 22.5 percent loss at higher qualifying doses, a best-case figure rather than the norm. Shares an active ingredient with Mounjaro and Zepbound.

Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm welcome for Holyoke telehealth patients.

How Telehealth Works for Holyoke

No waiting rooms, no commute across Holyoke traffic. Everything happens online. You answer a focused intake quiz about your goals and medical background, Dr. Anjmun Sharma reviews it and sees you by secure video (usually within 48 hours), and if a compounded GLP-1 is appropriate she sends the prescription to a state-licensed 503(a) pharmacy. That pharmacy ships your semaglutide or tirzepatide to your Holyoke home in cold-pack packaging that keeps it cool the whole way. Follow-up visits are by video as well, so dose adjustments and questions are handled from wherever you are in .

Frequently Asked Questions, Holyoke

I am searching for weight loss care near Holyoke. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Holyoke, Massachusetts connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Holyoke?

Not at all. The telehealth format covers Holyoke patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Holyoke in cold-pack packaging built to keep it cool and stable.

What are the program costs for Holyoke patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Holyoke patients face no distance surcharge.

What areas of Holyoke do you serve?

We serve patients from across Holyoke by telehealth, including downtown Holyoke and the greater Pioneer Valley of Hampden County.

Who qualifies for the program in Holyoke?

Eligibility for Holyoke patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.

Holyoke Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Holyoke, Massachusetts by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.